...
首页> 外文期刊>Key Engineering Materials >Tricalcium-Phosphate/Hydroxyapatite Bone Graft Extender for Use in Impaction Grafting Revision Surgery - An in Vitro Study in Human Femora
【24h】

Tricalcium-Phosphate/Hydroxyapatite Bone Graft Extender for Use in Impaction Grafting Revision Surgery - An in Vitro Study in Human Femora

机译:磷酸三钙/羟基磷灰石骨接枝扩展物用于冲击式接骨翻修手术-人股骨的体外研究

获取原文
获取原文并翻译 | 示例

摘要

Impacted morsellised allografts have successfully been used to address the problem of poor bone stock in revision surgery. However, concern exists about pathogen transmission, high cost and shortage of supply of donor bone. Bone graft extenders, such as tricalciumphosphate (TCP) and hydroxyapatite (HA), have been developed to minimize the use of donor bone. In a human cadaver model we evaluated the surgical and mechanical feasibility of a TCP/HA bone graft extender during impaction grafting revision surgery. TCP/HA allograft mix increased the risk of producing a fissure in the femur during the impaction procedure, but provided a higher initial mechanical stability as compared to bone graft alone (subsidence ratio graft: TCP/HA = 2.34). If surgeons are properly trained, this type of graft extender can be viable for impaction grafting revision surgery.
机译:散乱的异体移植物已成功用于解决翻修手术中骨储备不足的问题。然而,存在对病原体传播,高成本和供体骨供应短缺的担忧。已经开发出骨移植增量剂,例如磷酸三钙(TCP)和羟基磷灰石(HA),以最大程度地减少供体骨的使用。在人类尸体模型中,我们评估了TCP / HA植骨扩展器在植骨修复手术中的手术和机械可行性。 TCP / HA同种异体移植物增加了在撞击过程中在股骨中产生裂痕的风险,但与单独的骨移植物相比,提供了更高的初始机械稳定性(下沉比:TCP / HA = 2.34)。如果对外科医生进行了适当的培训,则这种类型的移植物延长器可适用于冲击式移植物翻修手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号